Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Baker Brothers Advisors LLC

Investor type Hedge Fund


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 28
Average round size
The average size of a deal this fund participated in
Portfolio companies 16
Rounds per year 1.27
Lead investments 4
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 13
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Medical

The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.

The overall number of key employees were 1.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Baker Brothers Advisors LLC, startups are often financed by New Leaf Venture Partners, Alta Partners, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are Ventures West, New Leaf Venture Partners, Sofinnova Investments. In the next rounds fund is usually obtained by New Leaf Venture Partners, Redmile Group, Yasuda Enterprise Development.

The important activity for fund was in 2007. Comparing to the other companies, this Baker Brothers Advisors LLC performs on 14 percentage points more the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Diagnostics. The fund has exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Synageva BioPharma, diaDexus, MethylGene

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Baker Brothers Advisors LLC:
Typical Co-investors
Baker Brothers Advisors LLC is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Baker Brothers Advisors LLC:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Biosensors Japan, Tokyo
Capital Point Israel, Tel Aviv, Tel Aviv District
Emerging Technology Partners California, San Francisco, United States
Forbes Family Trust New York, New York, United States
Fountainhead Investment Partners -
Global Millennial Capital Dubai, United Arab Emirates
Janchor Partners China, Hong Kong, Hong Kong Island
Kingdom Holding Company Ar Riyad, Riyadh, Saudi Arabia
Kington Capital China, Jiangsu, Suzhou
Musketeer Capital Haverford, Pennsylvania, United States
Rogozhin Asset Management Moscow, Moscow, Russia
Senshu Ikeda Holdings Japan, Osaka, Osaka Prefecture
Shaw Communications Alberta, Calgary, Canada
Strategic Equities -
Torstar Corporation Canada, Ontario, Toronto
V8 Capital Partners Ebène, Mauritius, Plaines Wilhems
Venvest Capital California, Santa Monica, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

DBV Technologies

Health Care
Health Diagnostics
$213M09 Jun 2022 Bagneux, Ile-de-France, France

FORMA Therapeutics

Health Care
$100M19 Dec 2019 Massachusetts, United States

IGM Biosciences

$102M08 Jul 2019 Mountain View, California, United States

Hookipa Pharma

Clinical Trials
$37M26 Feb 2019 Vienna, Austria

Cabaletta Bio

Health Care
$50M03 Jan 2019 Philadelphia, Pennsylvania, United States

Cabaletta Bio

Health Care
$38M08 Nov 2018 Philadelphia, Pennsylvania, United States


Health Diagnostics
23 Mar 2018 California, United States

Kiniksa Pharmaceuticals

$200M01 Feb 2018 Bermuda, Devonshire, Bermuda

Hookipa Pharma

Clinical Trials
$60M11 Dec 2017 Vienna, Austria


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Baker Brothers Advisors LLC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: